Albert Street Medical Centre, Taree, NSW.
Med J Aust. 2012 Apr 2;196(6):391-4. doi: 10.5694/mja11.11338.
To assess whether patients receiving opioid substitution therapy (OST) in general practice cause other patients sufficient distress to change practices--a perceived barrier that prevents general practitioners from prescribing OST.
DESIGN, SETTING AND PARTICIPANTS: A cross-sectional questionnaire-based survey of consecutive adult patients in the waiting rooms of a network of research general practices in New South Wales during August-December 2009.
Prevalence of disturbing waiting room experiences where drug intoxication was considered a factor, discomfort about sharing the waiting room with patients being treated for drug addiction, and likelihood of changing practices if the practice provided specialised care for patients with opiate addiction.
From 15 practices (eight OST-prescribing), 1138 of 1449 invited patients completed questionnaires (response rate, 78.5%). A disturbing experience in any waiting room at any time was reported by 18.0% of respondents (203/1130), with only 3.1% (35/1128) reporting that drug intoxication was a contributing factor. However, 39.3% of respondents (424/1080) would feel uncomfortable sharing the waiting room with someone being treated for drug addiction. Respondents were largely unaware of the OST-prescribing status of the practice (12.1% of patients attending OST-prescribing practices [70/579] correctly reported this). Only 15.9% of respondents (165/1037) reported being likely to change practices if theirs provided specialised care for opiate-addicted patients. In contrast, 28.7% (302/1053) were likely to change practices if consistently kept waiting more than 30 minutes, and 26.6% (275/1033) would likely do so if consultation fees increased by $10.
Despite the frequency of stigmatising attitudes towards patients requiring treatment for drug addiction, GPs' concerns that prescribing OST in their practices would have a negative impact on other patients' waiting room experiences or on retention of patients seem to be unfounded.
评估在一般实践中接受阿片类药物替代疗法(OST)的患者是否会给其他患者带来足够的困扰,从而改变实践——这是一种普遍的看法,认为这是阻止全科医生开具 OST 的障碍。
设计、环境和参与者:这是一项基于问卷调查的横断面研究,于 2009 年 8 月至 12 月在新南威尔士州一个研究性全科医生网络的候诊室对连续的成年患者进行。
药物中毒被认为是一个因素时,候诊室令人不安的经历的发生率、与正在接受药物成瘾治疗的患者共用候诊室的不适程度,以及如果实践为阿片类药物成瘾患者提供专门护理,改变实践的可能性。
在 15 个实践中(8 个 OST 处方),邀请的 1449 名患者中有 1138 名完成了问卷(应答率为 78.5%)。18.0%(203/1130)的受访者报告说,在任何时候的任何候诊室都有过令人不安的经历,只有 3.1%(35/1128)的受访者报告说药物中毒是一个促成因素。然而,39.3%(424/1080)的受访者会感到不舒服与正在接受药物成瘾治疗的人共用候诊室。受访者对实践中 OST 处方的情况知之甚少(在接受 OST 处方的实践中,12.1%的患者[70/579]正确报告了这一点)。只有 15.9%的受访者(165/1037)报告说,如果他们的实践为阿片类药物成瘾患者提供专门护理,他们可能会改变实践。相比之下,如果每次就诊都要等待超过 30 分钟,28.7%(302/1053)的人更有可能改变实践,如果咨询费增加 10 美元,26.6%(275/1033)的人更有可能改变实践。
尽管对需要治疗药物成瘾的患者存在污名化的态度,但全科医生担心在实践中开具 OST 会对其他患者的候诊室体验或患者保留产生负面影响,这似乎是没有根据的。